Scarica l'app Stockscreener
7.74
1.44%
0.11
Dopo l'orario di chiusura:
7.74
Precedente Chiudi:
$7.63
Aprire:
$7.77
Volume 24 ore:
179.24K
Relative Volume:
0.92
Capitalizzazione di mercato:
$289.54M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
154.80
EPS:
0.05
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
+0.13%
1M Prestazione:
-6.75%
6M Prestazione:
+30.30%
1 anno Prestazione:
+28.15%
Intervallo 1D:
$7.55
$7.77
Intervallo di 1 settimana:
$7.03
$7.86
Portata 52W:
$3.6793
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Confronta LFCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.74 | 267.32M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-21 | Iniziato | William Blair | Outperform |
| 2024-09-05 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Should you hold or exit Lifecore Biomedical Inc. nowMulti-Bagger Detection with Trend Tools - Newser
Volume spikes in Lifecore Biomedical Inc. stock – what they meanWeekly Growth Portfolio Performance Summary - Newser
What to expect from Lifecore Biomedical Inc. in the next 30 daysFree Entry Alert With Low Drawdown Strategy - Newser
Short interest data insights for Lifecore Biomedical Inc.Quarterly Investment Outlook and Key Summary - Newser
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Using Ichimoku Cloud for Lifecore Biomedical Inc. technicalsTechnical Insight Guide for Safer Trades - Newser
Custom strategy builders for tracking Lifecore Biomedical Inc.Daily Market Movers Screener with Filters - Newser
Lifecore Biomedical Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingPredictable Return Strategy with AI Support - Newser
Lifecore Biomedical Exceeds Revenue Estimates, Reports Q4 $36.4M and EPS Loss of $0.06 - AInvest
Lifecore Biomedical Inc. Attempts Reversal From Key SupportAI Forecast for Trending Stocks Indicates Upside - beatles.ru
Lifecore Biomedical 2025 Q4 Earnings Significant Net Loss Improvement - AInvest
Lifecore (LFCR) Q4 Revenue Beats 3% - AOL.com
Lifecore Biomedical shares fall 3.61% intraday despite reporting $128.9 million in fiscal 2025 revenue. - AInvest
Lifecore Biomedical: Navigating Headwinds with Strategic Resilience and Long-Term Growth Catalysts - AInvest
Lifecore Biomedical's Q4 2025: Unpacking Key Contradictions on Tariffs, Demand, and Market Growth - AInvest
The one-year returns have been decent for Lifecore Biomedical (NASDAQ:LFCR) shareholders despite underlying losses increasing - simplywall.st
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss - Investing.com Nigeria
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss By Investing.com - Investing.com South Africa
Lifecore Biomedical: Fiscal Q4 Earnings Snapshot - Connecticut Post
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : Lifecore Biomedical, Inc., Q4 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Signal strength of Lifecore Biomedical Inc. stock in tech scannersPredictable Income Summary for Long-Term Trades - Newser
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates - sharewise.com
Lifecore Biomedical’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating - TipRanks
Lifecore Biomedical earnings missed by $0.02, revenue topped estimates - Investing.com South Africa
Lifecore Biomedical reports $128.9mln FY25 revenue, meets full-year guidance. - AInvest
Lifecore Biomedical Reports Q4 and FY25 Financial Results, Achieves Full-Year Guidance, and Provides Corporate Update - AInvest
Laughing Water Capital's Top 5 Holdings for Q2 2025 - AInvest
Laughing Water Capital's Top 5 Positions For Q2 2025 - Seeking Alpha
Lifecore Biomedical Reports 2025 Financial Results - TipRanks
Momentum divergence signals in Lifecore Biomedical Inc. chartFree Early Entry Tips With Low Risk Zone - Newser
How hedge fund analytics apply to Lifecore Biomedical Inc. stockBreakout Monitoring with Momentum Analysis - Newser
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsPortfolio Review Summary with Five-Year Outlook - Newser
Can Lifecore Biomedical Inc. stock recover from recent declineDay Trading Setup Forecast with Trend Model - Newser
Lifecore Biomedical Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
What drives Lifecore Biomedical Inc. stock priceBuild a diversified portfolio for stability - Jammu Links News
What catalysts could drive Lifecore Biomedical Inc. stock higher in 2025Rapid return acceleration - Jammu Links News
What institutional investors are buying Lifecore Biomedical Inc. stockInvest confidently with professional market insights - Jammu Links News
What is the risk reward ratio of investing in Lifecore Biomedical Inc. stockInvest smarter with actionable stock recommendations - Jammu Links News
When is Lifecore Biomedical Inc. stock expected to show significant growthAchieve remarkable returns with smart investing - Jammu Links News
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):